Confidential reports designed to help GPs improve the quality of their prescribing and patient safety are available for practices that contribute to CPRD.
CPRD and the Royal College of GPs (RCGP) have developed confidential bespoke practice and patient-level drug prescribing reports, available for free for GP practices contributing to CPRD. The reports provide a pseudonymised list of patients at the practice so that GPs can re-identify and review their care plans. Reports also show the practice’s prescription rate benchmarked against other participating GP practices. Each report covers a selection of safety indicators and enables collection of evidence for annual appraisals under Domain 2 (Safety and Quality). Below you can view example reports, created using sample data. The latest report is on prescribing of valproate to women of childbearing potential. Managing the prescription of psychotropic medication for adults with learning disabilities, autism, or both in order to minimise potential negative impacts is a challenging process for primary care. In order to support GPs and primary care pharmacists with this, reports sent to contributing practices in January 2019 included the following indicators: These indicators are based on NHS England's Stopping Over-Medication of People with a Learning Disability, Autism or Both (STOMP) project, which aims to improve the quality of life of people with a learning disability, autism or both by reducing the potential harm of inappropriate psychotropic drugs. For each of the indicators, the reports: The heart and circulatory system QI report includes three indicators taken from the RCGP patient safety toolkit and one that was suggested by NICE: The latest heart and circulatory system reports are being sent to contributing practices from summer 2019. Below you can view an example report, created using sample data. GPs are invited to take an active role in suggesting topics for future reports. Dr Tommy Hunter has written a blog here about how he has used the report at his own practice. Unlike much of the performance measurement information that a practice receives, this report is for practice-use only and not in the public domain. On the RCGP website you can view videos by Dr Scott Jamieson, RCGP Scotland Quality Improvement lead, providing an overview of the data reports and how they can be used by practices. For more information about the new reports, contact the RCGP lead for this project, David Mullett at david.mullett@rcgp.org.uk. Publication: Prescribing of valproate to women of childbearing potential
Patient safety and prescribing in patients with a learning disability, autism or both
Heart and circulatory system reports
To receive the reports, practices must first join CPRD. 
Further information
[Page last reviewed 5 November 2019]
